An Open-label, Multi-center, One Sequence Cross-over Drug Interaction Study to Investigate the Effect of Tocilizumab (TCZ, RO4877533) on the Pharmacokinetics and Pharmacodynamics of an Oral Contraceptive (OC) in Female Patients With Active Rheumatoid Arthritis (RA).
Phase of Trial: Phase III
Latest Information Update: 28 Oct 2013
At a glance
- Drugs Tocilizumab (Primary) ; Ethinylestradiol/norethisterone
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- Sponsors Roche
- 10 Jun 2017 Biomarkers information updated
- 17 Jul 2012 Actual patient number changed from 45 to 46 according to ClinicalTrials.gov.
- 06 Jul 2012 Actual patient number changed from 44 to 45 according to ClinicalTrials.gov.